Drug Shortage Report for LAMICTAL
Report ID |
20136 |
Drug Identification Number |
02142112 |
Brand name |
LAMICTAL |
Common or Proper name |
Lamotrigine tablets |
Company Name |
GLAXOSMITHKLINE INC |
Market Status |
MARKETED |
Active Ingredient(s) |
LAMOTRIGINE |
Strength(s) |
150MG |
Dosage form(s) |
TABLET |
Route of administration |
ORAL |
Packaging size |
60's |
ATC code |
N03AX |
ATC description |
ANTIEPILEPTICS |
Reason for shortage |
Shortage of an active ingredient. |
Anticipated start date |
|
Actual start date |
2017-10-26 |
Estimated end date |
2018-03-20 |
Actual end date |
2018-03-15 |
Shortage status |
Resolved |
Updated date |
2018-03-16 |
Company comments |
|
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other
versions.